HSSCX
Price
$25.96
Change
-$0.18 (-0.69%)
Updated
Dec 26 closing price
Net Assets
49.53M
RPFGX
Price
$80.60
Change
-$0.03 (-0.04%)
Updated
Dec 26 closing price
Net Assets
1.23B
Interact to see
Advertisement

HSSCX vs RPFGX

Header iconHSSCX vs RPFGX Comparison
Open Charts HSSCX vs RPFGXBanner chart's image
Emerald Finance & Bking Innovt Fd C
Price$25.96
Change-$0.18 (-0.69%)
VolumeN/A
Net Assets49.53M
Davis Financial A
Price$80.60
Change-$0.03 (-0.04%)
VolumeN/A
Net Assets1.23B
HSSCX vs RPFGX Comparison Chart in %
View a ticker or compare two or three
VS
HSSCX vs. RPFGX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSSCX is a Hold and RPFGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPFGX has more cash in the bank: 1.23B vs. HSSCX (49.5M). RPFGX pays higher dividends than HSSCX: RPFGX (1.26) vs HSSCX (0.00). HSSCX was incepted earlier than RPFGX: HSSCX (26 years) vs RPFGX (35 years). HSSCX (2.44) is less costly to investors than RPFGX (0.94). HSSCX is a more actively managed with annual turnover of: 32.00 vs. RPFGX (2.00). RPFGX has a lower initial minimum investment than HSSCX: RPFGX (1000) vs HSSCX (2000). RPFGX annual gain was more profitable for investors over the last year : 24.67 vs. HSSCX (12.58). RPFGX return over 5 years is better than : 98.65 vs. HSSCX (-9.87).
HSSCXRPFGXHSSCX / RPFGX
Total Expense Ratio2.440.94260%
Annual Report Gross Expense Ratio2.440.94260%
Fund Existence26 years35 years-
Gain YTD14.56326.23356%
Front LoadN/A5%-
Min. Initial Investment20001000200%
Min. Initial Investment IRAN/AN/A-
Net Assets49.5M1.23B4%
Annual Yield % from dividends0.001.26-
Returns for 1 year12.5824.6751%
Returns for 3 years52.7076.4469%
Returns for 5 years-9.8798.65-10%
Returns for 10 years-1.29122.85-1%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MENEF0.12N/A
+2.12%
Mene Inc.
EVVTY67.800.12
+0.18%
Evolution AB
CYDY0.28N/A
N/A
CytoDyn Inc.
FCXXF13.49N/A
N/A
First Cap Real Estate Investment Trust
NDATF0.01N/A
N/A
NDATALYZE CORP.